Mono Vaccine Market Strategies and Share 2031
Mono, also known as mononucleosis, is an infectious disease caused by the Epstein-Barr virus. Since this virus is transmitted primarily by saliva, it is also known as kissing disease. Other methods of transmission include exchanging drinks or utensils. Mono/kissing disease is caused by the Epstein-Barr virus, also known as human herpesvirus 4. The Epstein-Barr virus is the most common type of virus in humans, and it is one of eight types of human herpes virus family. Various companies are focusing on novel monovaccine research and development, which may spur industry players' interest in conducting research and development in this field of high unmet need. Currently, there is no approved Mono vaccine in the market.
MARKET DYNAMICS
Factors driving the growth of the mono vaccine market are the growing government initiatives, coupled with rising healthcare spending. However, the number of barriers in the development and gaining approval for EBV vaccines is expected to hamper the growth of the market. Moreover, increasing research and development activities by pharmaceutical companies is anticipated to boost the market growth.
MARKET SCOPE
The "Mono Vaccine Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of mono vaccine market with detailed market segmentation by application and end user. The mono vaccine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in mono vaccine market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The mono vaccine market is segmented on the basis of application and end user. On the basis of application, the market is categorized as mononucleosis, Endemic Burkitt's Lymphoma, Hodgkin's Lymphoma, gastric carcinomas, multiple sclerosis, and nasopharyngeal carcinoma. On the basis of end-user, the market is categorized as adults and children
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the mono vaccine market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The mono vaccine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting mono vaccine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the mono vaccine market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the mono vaccine market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The mono vaccine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting mono vaccine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the mono vaccine market in these regions.
MARKET PLAYERS
The report covers key developments in the mono vaccine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from mono vaccine market are anticipated to have lucrative growth opportunities in the future with the rising demand for mono vaccine in the global market. Below mentioned is the list of few companies engaged in the mono vaccine market.
The report also includes the profiles of key players in mono vaccine market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- GlaxoSmithKline plc
- Sanofi S.A.
- Pfizer Inc
- CNBG
- Merck
- Neuron Biotech
- MSD
- Serum Institute of India
- Biomed Pvt. Ltd
- Baxter International
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Mono Vaccine Market - By Application
1.3.2 Mono Vaccine Market - By End user
1.3.3 Mono Vaccine Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MONO VACCINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. MONO VACCINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. MONO VACCINE MARKET - GLOBAL MARKET ANALYSIS
6.1. MONO VACCINE - GLOBAL MARKET OVERVIEW
6.2. MONO VACCINE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. MONO VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET FORECASTS AND ANALYSIS
7.3. MONONUCLEOSIS
7.3.1. Overview
7.3.2. Mononucleosis Market Forecast and Analysis
7.4. ENDEMIC BURKITT'S LYMPHOMA
7.4.1. Overview
7.4.2. Endemic Burkitt's lymphoma Market Forecast and Analysis
7.5. HODGKIN'S LYMPHOMA
7.5.1. Overview
7.5.2. Hodgkin's lymphoma Market Forecast and Analysis
7.6. GASTRIC CARCINOMAS
7.6.1. Overview
7.6.2. Gastric carcinomas Market Forecast and Analysis
7.7. MULTIPLE SCLEROSIS
7.7.1. Overview
7.7.2. Multiple sclerosis Market Forecast and Analysis
7.8. NASOPHARYNGEAL
7.8.1. Overview
7.8.2. Nasopharyngeal Market Forecast and Analysis
7.9. CARCINOMA
7.9.1. Overview
7.9.2. Carcinoma Market Forecast and Analysis
8. MONO VACCINE MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. ADULTS
8.3.1. Overview
8.3.2. Adults Market Forecast and Analysis
8.4. CHILDREN
8.4.1. Overview
8.4.2. Children Market Forecast and Analysis
9. MONO VACCINE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Mono Vaccine Market Overview
9.1.2 North America Mono Vaccine Market Forecasts and Analysis
9.1.3 North America Mono Vaccine Market Forecasts and Analysis - By Application
9.1.4 North America Mono Vaccine Market Forecasts and Analysis - By End user
9.1.5 North America Mono Vaccine Market Forecasts and Analysis - By Countries
9.1.5.1 United States Mono Vaccine Market
9.1.5.1.1 United States Mono Vaccine Market by Application
9.1.5.1.2 United States Mono Vaccine Market by End user
9.1.5.2 Canada Mono Vaccine Market
9.1.5.2.1 Canada Mono Vaccine Market by Application
9.1.5.2.2 Canada Mono Vaccine Market by End user
9.1.5.3 Mexico Mono Vaccine Market
9.1.5.3.1 Mexico Mono Vaccine Market by Application
9.1.5.3.2 Mexico Mono Vaccine Market by End user
9.2. EUROPE
9.2.1 Europe Mono Vaccine Market Overview
9.2.2 Europe Mono Vaccine Market Forecasts and Analysis
9.2.3 Europe Mono Vaccine Market Forecasts and Analysis - By Application
9.2.4 Europe Mono Vaccine Market Forecasts and Analysis - By End user
9.2.5 Europe Mono Vaccine Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Mono Vaccine Market
9.2.5.1.1 Germany Mono Vaccine Market by Application
9.2.5.1.2 Germany Mono Vaccine Market by End user
9.2.5.2 France Mono Vaccine Market
9.2.5.2.1 France Mono Vaccine Market by Application
9.2.5.2.2 France Mono Vaccine Market by End user
9.2.5.3 Italy Mono Vaccine Market
9.2.5.3.1 Italy Mono Vaccine Market by Application
9.2.5.3.2 Italy Mono Vaccine Market by End user
9.2.5.4 Spain Mono Vaccine Market
9.2.5.4.1 Spain Mono Vaccine Market by Application
9.2.5.4.2 Spain Mono Vaccine Market by End user
9.2.5.5 United Kingdom Mono Vaccine Market
9.2.5.5.1 United Kingdom Mono Vaccine Market by Application
9.2.5.5.2 United Kingdom Mono Vaccine Market by End user
9.2.5.6 Rest of Europe Mono Vaccine Market
9.2.5.6.1 Rest of Europe Mono Vaccine Market by Application
9.2.5.6.2 Rest of Europe Mono Vaccine Market by End user
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Mono Vaccine Market Overview
9.3.2 Asia-Pacific Mono Vaccine Market Forecasts and Analysis
9.3.3 Asia-Pacific Mono Vaccine Market Forecasts and Analysis - By Application
9.3.4 Asia-Pacific Mono Vaccine Market Forecasts and Analysis - By End user
9.3.5 Asia-Pacific Mono Vaccine Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Mono Vaccine Market
9.3.5.1.1 Australia Mono Vaccine Market by Application
9.3.5.1.2 Australia Mono Vaccine Market by End user
9.3.5.2 China Mono Vaccine Market
9.3.5.2.1 China Mono Vaccine Market by Application
9.3.5.2.2 China Mono Vaccine Market by End user
9.3.5.3 India Mono Vaccine Market
9.3.5.3.1 India Mono Vaccine Market by Application
9.3.5.3.2 India Mono Vaccine Market by End user
9.3.5.4 Japan Mono Vaccine Market
9.3.5.4.1 Japan Mono Vaccine Market by Application
9.3.5.4.2 Japan Mono Vaccine Market by End user
9.3.5.5 South Korea Mono Vaccine Market
9.3.5.5.1 South Korea Mono Vaccine Market by Application
9.3.5.5.2 South Korea Mono Vaccine Market by End user
9.3.5.6 Rest of Asia-Pacific Mono Vaccine Market
9.3.5.6.1 Rest of Asia-Pacific Mono Vaccine Market by Application
9.3.5.6.2 Rest of Asia-Pacific Mono Vaccine Market by End user
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Mono Vaccine Market Overview
9.4.2 Middle East and Africa Mono Vaccine Market Forecasts and Analysis
9.4.3 Middle East and Africa Mono Vaccine Market Forecasts and Analysis - By Application
9.4.4 Middle East and Africa Mono Vaccine Market Forecasts and Analysis - By End user
9.4.5 Middle East and Africa Mono Vaccine Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Mono Vaccine Market
9.4.5.1.1 South Africa Mono Vaccine Market by Application
9.4.5.1.2 South Africa Mono Vaccine Market by End user
9.4.5.2 Saudi Arabia Mono Vaccine Market
9.4.5.2.1 Saudi Arabia Mono Vaccine Market by Application
9.4.5.2.2 Saudi Arabia Mono Vaccine Market by End user
9.4.5.3 U.A.E Mono Vaccine Market
9.4.5.3.1 U.A.E Mono Vaccine Market by Application
9.4.5.3.2 U.A.E Mono Vaccine Market by End user
9.4.5.4 Rest of Middle East and Africa Mono Vaccine Market
9.4.5.4.1 Rest of Middle East and Africa Mono Vaccine Market by Application
9.4.5.4.2 Rest of Middle East and Africa Mono Vaccine Market by End user
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Mono Vaccine Market Overview
9.5.2 South and Central America Mono Vaccine Market Forecasts and Analysis
9.5.3 South and Central America Mono Vaccine Market Forecasts and Analysis - By Application
9.5.4 South and Central America Mono Vaccine Market Forecasts and Analysis - By End user
9.5.5 South and Central America Mono Vaccine Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Mono Vaccine Market
9.5.5.1.1 Brazil Mono Vaccine Market by Application
9.5.5.1.2 Brazil Mono Vaccine Market by End user
9.5.5.2 Argentina Mono Vaccine Market
9.5.5.2.1 Argentina Mono Vaccine Market by Application
9.5.5.2.2 Argentina Mono Vaccine Market by End user
9.5.5.3 Rest of South and Central America Mono Vaccine Market
9.5.5.3.1 Rest of South and Central America Mono Vaccine Market by Application
9.5.5.3.2 Rest of South and Central America Mono Vaccine Market by End user
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL MONO VACCINE MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. MONO VACCINE MARKET, KEY COMPANY PROFILES
12.1. GLAXOSMITHKLINE PLC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. SANOFI S.A.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PFIZER INC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. CNBG
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MERCK
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. NEURON BIOTECH
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. MSD
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SERUM INSTITUTE OF INDIA
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. BIOMED PVT. LTD
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. BAXTER INTERNATIONAL
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. GlaxoSmithKline plc
2. Sanofi S.A.
3. Pfizer Inc
4. CNBG
5. Merck
6. Neuron Biotech
7. MSD
8. Serum Institute of India
9. Biomed Pvt. Ltd
10. Baxter International
11. Biokangtai
12. JN-International Medical Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For